{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T19:05:12Z","timestamp":1771787112162,"version":"3.50.1"},"reference-count":29,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"unspecified","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101605"],"award-info":[{"award-number":["82101605"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tongji Hospital Key Funding","award":["2024A14"],"award-info":[{"award-number":["2024A14"]}]},{"name":"Interdiciplinary Research Program of Hust","award":["2024JCYJ004"],"award-info":[{"award-number":["2024JCYJ004"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,2,4]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To develop and validate a mortality-risk prediction model for patients with advanced splenomegaly-subtype schistosomiasis, enabling accurate prognosis assessment and informed resource allocation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective, population-based cohort study using clinical data from a single-centre registry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Endemic regions of Hubei Province, China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>The study includes 628 patients with advanced splenomegaly-subtype schistosomiasis from the Hubei Provincial Advanced Schistosomiasis Registry between September 2014 and January 2015. The splenomegaly subtype is defined as splenomegaly extending below the umbilical line or with a transverse diameter exceeding the mid-abdominal line. We divided the study population into two cohorts. The derivation cohort included 452 patients selected from several counties within the registry. These patients had a confirmed diagnosis of advanced splenomegaly-subtype schistosomiasis. Only those with complete data were retained. The external validation cohort comprised 176 patients from geographically distinct counties in the same registry, and the same inclusion and exclusion criteria were applied. 10-fold cross-validation was employed to evaluate the model\u2019s generalisation on the derivation cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome measures<\/jats:title>\n                    <jats:p>6-year all-cause mortality was the outcome measure. Baseline variables, included age, serum aspartate aminotransferase, albumin, splenectomy history and frequency of ascites \u22655 episodes were analysed using Cox proportional hazards regression. Model performance was assessed via C-statistics, net reclassification improvement (NRI) and integrated discrimination improvement (IDI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five predictors were integrated into the mortality risk model. The C-statistic for predicting 6-year mortality was 0.79 (95% CI 0.74 to 0.83) in the derivation cohort, with robust validation in the external validation cohort (0.78, 95%\u2009CI 0.70 to 0.86). Simplified models using subsets of predictors showed slight reductions in discrimination (NRI and IDI). Patients with a frequency of ascites \u22655 episodes had significantly lower survival rates and should be given special attention in clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The validated prediction model identifies high-risk patients using accessible clinical variables. The approach may optimise prognostication and prioritisation of healthcare resources for advanced schistosomiasis. The model\u2019s performance remains to be confirmed in a prospectively enrolled cohort.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-111981","type":"journal-article","created":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T18:35:29Z","timestamp":1771785329000},"page":"e111981","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Prediction of 6-year mortality in advanced splenomegaly-subtype schistosomiasis: a retrospective cohort study from Hubei, China"],"prefix":"10.1136","volume":"16","author":[{"given":"Hao","family":"Zhang","sequence":"first","affiliation":[{"name":"The Second Clinical College, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[{"name":"The First Clinical College, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqi","family":"Li","sequence":"additional","affiliation":[{"name":"The First Clinical College, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingxiong","family":"Ma","sequence":"additional","affiliation":[{"name":"The Second Clinical College, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4600-2784","authenticated-orcid":false,"given":"Lanyue","family":"Pan","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Department and Institute of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziran","family":"Zhou","sequence":"additional","affiliation":[{"name":"The Second Clinical College, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3911-6978","authenticated-orcid":false,"given":"Guo","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,2,22]]},"reference":[{"key":"2026022210351656000_16.2.e111981.1","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/S1473-3099(22)00221-3","article-title":"Review of 2022 WHO guidelines on the control and elimination of schistosomiasis","volume":"22","author":"Lo","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2026022210351656000_16.2.e111981.2","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080969","article-title":"Discrepancies in neglected tropical diseases burden estimates in China: comparative study of real-world data and Global Burden of Disease 2021 data (2004-2020)","volume":"388","author":"Yang","year":"2025","journal-title":"BMJ"},{"key":"2026022210351656000_16.2.e111981.3","first-page":"451","article-title":"Diagnosis and treatment of schistosomiasis japonica-concensuses among ex- perts in Hunan, Hubei and Jiangxi provinces","volume":"27","author":"Deng","year":"2015","journal-title":"Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi"},{"key":"2026022210351656000_16.2.e111981.4","first-page":"235","article-title":"Recommendation of a new clinical classification of advanced schistosomiasis","volume":"24","author":"Deng","year":"2012","journal-title":"Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi"},{"key":"2026022210351656000_16.2.e111981.5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001149","article-title":"Chronic hepatosplenomegaly in African school children: a common but neglected morbidity associated with schistosomiasis and malaria","volume":"5","author":"Wilson","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"2026022210351656000_16.2.e111981.6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.21106\/ijma.100","article-title":"China-Africa Health Development Initiatives: Benefits and Implications for Shaping Innovative and Evidence-informed National Health Policies and Programs in Sub-saharan African Countries","volume":"5","author":"Tambo","year":"2016","journal-title":"Int J MCH AIDS"},{"key":"2026022210351656000_16.2.e111981.7","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1007\/s00436-014-4143-y","article-title":"Guideline adherence for the treatment of advanced schistosomiasis japonica in Hubei, China","volume":"113","author":"Zhong","year":"2014","journal-title":"Parasitol Res"},{"key":"2026022210351656000_16.2.e111981.8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007174","article-title":"Reversal of liver fibrosis after splenectomy in a patient with advanced schistosomiasis japonica: A case report with 4-year follow-up","volume":"13","author":"Song","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"2026022210351656000_16.2.e111981.9","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1007\/s00431-024-05623-2","article-title":"Schistosomiasis in migrant children and adolescents in a paediatric tropical referral unit in Spain: diagnosis and long-term management challenges","volume":"183","author":"Rodr\u00edguez-Molino","year":"2024","journal-title":"Eur J Pediatr"},{"key":"2026022210351656000_16.2.e111981.10","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"BMJ"},{"key":"2026022210351656000_16.2.e111981.11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39339.610000.BE"},{"key":"2026022210351656000_16.2.e111981.12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ebiom.2019.08.028","article-title":"Derivation and external validation of a model to predict 2-year mortality risk of patients with advanced schistosomiasis after discharge","volume":"47","author":"Li","year":"2019","journal-title":"EBioMedicine"},{"key":"2026022210351656000_16.2.e111981.13","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.000304"},{"key":"2026022210351656000_16.2.e111981.14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0013134","article-title":"A model predicting the 6-year all cause mortality of patients with advanced schistosomiasis after discharge: Derived from a large population-based cohort study","volume":"19","author":"Pan","year":"2025","journal-title":"PLoS Negl Trop Dis"},{"key":"2026022210351656000_16.2.e111981.15","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5804"},{"key":"2026022210351656000_16.2.e111981.16","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwm305"},{"key":"2026022210351656000_16.2.e111981.17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.12126"},{"key":"2026022210351656000_16.2.e111981.18","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/eurheartj\/ehy345","article-title":"Application of net reclassification index to non-nested and point-based risk prediction models: a review","volume":"40","author":"Thomas","year":"2019","journal-title":"Eur Heart J"},{"key":"2026022210351656000_16.2.e111981.19","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/S0140-6736(24)02417-6","article-title":"Halving premature death and improving quality of life at all ages: cross-country analyses of past trends and future directions","volume":"404","author":"Norheim","year":"2024","journal-title":"Lancet"},{"key":"2026022210351656000_16.2.e111981.20","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afac313","article-title":"A novel prognostic nomogram for older patients with acute-on-chronic liver diseases (AoCLD): a nationwide, multicentre, prospective cohort study","volume":"52","author":"Zou","year":"2023","journal-title":"Age Ageing"},{"key":"2026022210351656000_16.2.e111981.21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.actatropica.2008.05.004","article-title":"Aging and immune response in chronic human schistosomiasis","volume":"108","author":"Comin","year":"2008","journal-title":"Acta Trop"},{"key":"2026022210351656000_16.2.e111981.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2010.05.020"},{"key":"2026022210351656000_16.2.e111981.23","doi-asserted-by":"publisher","DOI":"10.1007\/BF01655279"},{"key":"2026022210351656000_16.2.e111981.24","doi-asserted-by":"crossref","first-page":"101467","DOI":"10.1016\/j.tmaid.2019.101467","article-title":"The impact of schistosomiasis co-infection in the presentation of viral hepatitis B in migrants: An observational study in non-endemic area","volume":"35","author":"Marchese","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"2026022210351656000_16.2.e111981.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.06.017"},{"key":"2026022210351656000_16.2.e111981.26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3748\/wjg.v21.i3.711","article-title":"Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine","volume":"21","author":"Sookoian","year":"2015","journal-title":"World J Gastroenterol"},{"key":"2026022210351656000_16.2.e111981.27","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.782029"},{"key":"2026022210351656000_16.2.e111981.28","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2015.993313"},{"key":"2026022210351656000_16.2.e111981.29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-079309","article-title":"Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial","volume":"14","author":"Torp","year":"2024","journal-title":"BMJ Open"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-111981","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T18:35:31Z","timestamp":1771785331000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-111981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,22]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1136\/bmjopen-2025-111981"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-111981","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}